Canadian Online Pharmacy

CDER New June 26, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 25, 2012


New and Generic Drug Approvals

June 22, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Cellcept mycophenolate mofetil Capsule; Oral Roche Palo Labeling Revision
Cellcept mycophenolate mofetil hydrochloride Injectable; Injection Roche Palo Labeling Revision
Cellcept mycophenolate mofetil Suspension; Oral Roche Palo Labeling Revision
Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp Sulfate amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate Capsule, Extended Release; Oral Actavis Elizabeth Approval
Incivek telaprevir Tablet; Oral Vertex Pharms Labeling Revision
Inspra eplerenone Tablet; Oral Gd Searle Llc Labeling Revision
Myfortic mycophenolic acid Tablet, Delayed Release; Oral Novartis Labeling Revision
Normocarb Hf 25 magnesium chloride; sodium bicarbonate; sodium chloride Solution; Injection Dialysis Sups Labeling Revision
Normocarb Hf 35 magnesium chloride; sodium bicarbonate; sodium chloride Solution; Injection Dialysis Sups Labeling Revision
Sustiva efavirenz Capsule; Oral Bristol Myers Squibb Labeling Revision
Sustiva efavirenz Tablet; Oral Bristol Myers Squibb Labeling Revision
Temazepam temazepam Capsule; Oral Novel Labs Inc Chemistry New Strength

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery